Hanwha Q Cells Co. Ltd. (HQCL) Given “Neutral” Rating at Roth Capital
Hanwha Q Cells Co. Ltd. (NASDAQ:HQCL)‘s stock had its “neutral” rating restated by research analysts at Roth Capital in a research note issued to investors on Monday. They presently have a $10.00 target price on the stock, down from their previous target price of $13.00. Roth Capital’s price objective points to a potential upside of 13.25% from the stock’s previous close.
Separately, Zacks Investment Research cut Hanwha Q Cells Co. from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 9th.
Hanwha Q Cells Co. (NASDAQ:HQCL) traded down 6.09% during midday trading on Monday, hitting $8.79. The stock had a trading volume of 35,256 shares. Hanwha Q Cells Co. has a 52-week low of $8.74 and a 52-week high of $9.45. The company’s 50 day moving average price is $0.00 and its 200-day moving average price is $0.00.
Hanwha Q Cells Co. (NASDAQ:HQCL) last announced its earnings results on Tuesday, November 22nd. The company reported $0.50 EPS for the quarter, topping the Zacks’ consensus estimate of $0.21 by $0.29. The firm earned $707.80 million during the quarter, compared to analysts’ expectations of $653.40 million. Hanwha Q Cells Co. had a return on equity of 42.02% and a net margin of 6.73%. The business’s revenue for the quarter was up 65.7% on a year-over-year basis. On average, equities analysts expect that Hanwha Q Cells Co. will post $1.67 earnings per share for the current year.
ILLEGAL ACTIVITY NOTICE: This piece was reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally copied and republished in violation of international trademark and copyright laws. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2016/11/28/hanwha-q-cells-co-ltd-hqcl-given-neutral-rating-at-roth-capital.html.
Large investors have recently modified their holdings of the company. Morgan Stanley raised its stake in shares of Hanwha Q Cells Co. by 12.8% in the third quarter. Morgan Stanley now owns 181,537 shares of the company’s stock worth $2,035,000 after buying an additional 20,545 shares in the last quarter. KBC Group NV raised its stake in shares of Hanwha Q Cells Co. by 36.3% in the third quarter. KBC Group NV now owns 17,098 shares of the company’s stock worth $192,000 after buying an additional 4,554 shares in the last quarter. Guggenheim Capital LLC raised its stake in shares of Hanwha Q Cells Co. by 27.8% in the second quarter. Guggenheim Capital LLC now owns 493,596 shares of the company’s stock worth $7,108,000 after buying an additional 107,408 shares in the last quarter. Walleye Trading LLC raised its stake in shares of Hanwha Q Cells Co. by 1,166.7% in the second quarter. Walleye Trading LLC now owns 7,600 shares of the company’s stock worth $109,000 after buying an additional 7,000 shares in the last quarter. Finally, AJO LP acquired a new stake in shares of Hanwha Q Cells Co. during the second quarter worth about $171,000. 1.29% of the stock is owned by hedge funds and other institutional investors.
About Hanwha Q Cells Co.
Hanwha Q CELLS Co, Ltd., formerly Hanwha SolarOne Co, Ltd., is a global solar energy company engaged in the manufacturing of solar modules, and the development and management of downstream solar farms. It manufactures a range of photo voltaic (PV) cells and PV modules at its manufacturing facilities in China and Malaysia using manufacturing process technologies, including those developed at its research and development facilities in Germany.
Receive News & Stock Ratings for Hanwha Q Cells Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hanwha Q Cells Co. Ltd. and related stocks with our FREE daily email newsletter.